Lynne Bui
Directeur/Membre du Conseil chez THARIMMUNE, INC.
Fortune : - $ au 31/05/2024
Postes actifs de Lynne Bui
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| THARIMMUNE, INC. | Directeur/Membre du Conseil | 01/07/2021 | - |
| Independent Dir/Board Member | 01/07/2021 | - | |
Khloris Biosciences, Inc.
 Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA. | Directeur Général | 01/06/2017 | - |
| Fondateur | - | - | |
| President | 01/06/2017 | - | |
| Global Cancer Research Institute | Président | - | - |
| Fondateur | - | - | |
| GCRI Foundation, Inc. | Président | - | - |
| Fondateur | - | - |
Historique de carrière de Lynne Bui
Anciens postes connus de Lynne Bui
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Directeur Technique/Scientifique/R&D | - | - |
Intellikine LLC
 Intellikine LLC Pharmaceuticals: MajorHealth Technology Intellikine LLC develops and manufactures small molecule drugs for the treatment of cancer. The company focused on the development of potent, selective small molecule inhibitors of the PI3K/Akt/mTOR pathway for the treatment of cancer, inflammation and autoimmune disorders. Intellikine was founded on May 2nd, 2007 and is headquartered in La Jolla, CA. | Directeur Technique/Scientifique/R&D | - | - |
| EXELIXIS, INC. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Lynne Bui
| University of California, Berkeley | Undergraduate Degree |
| David Geffen School of Medicine | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 10 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Founder | 3 |
| Chairman | 2 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| THARIMMUNE, INC. | Health Technology |
| EXELIXIS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Khloris Biosciences, Inc.
Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA. | Commercial Services |
| Global Cancer Research Institute | |
| GCRI Foundation, Inc. | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Intellikine LLC
Intellikine LLC Pharmaceuticals: MajorHealth Technology Intellikine LLC develops and manufactures small molecule drugs for the treatment of cancer. The company focused on the development of potent, selective small molecule inhibitors of the PI3K/Akt/mTOR pathway for the treatment of cancer, inflammation and autoimmune disorders. Intellikine was founded on May 2nd, 2007 and is headquartered in La Jolla, CA. | Health Technology |
